NEW YORK (GenomeWeb News) – Life Technologies said after the close of the market on Tuesday that revenues in the second quarter increased 1 percent year over year.

The company also said that its board has approved a $750 million share repurchase program on top of the $62 million that remains from its existing repurchase program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.